The images show the revolutionary design of the robot, including one of its highly versatile surgical bio-mimicking arms.
The release of the photographs marks a major milestone for CMR, which aims to make minimal access surgery available to all the estimated six million people a year who could benefit and make it easier for laparoscopic surgeons to learn and perform the technique.
Versius was designed to be lightweight and easy to set up. The robotic arms measure their position and force thousands of times a second, making them safe to be around and easy to manoeuvre even during surgery.
The arms and wristed instruments give maximum flexibility to surgeons during a procedure. This ground-breaking design allows them to work in a way that reduces physical and mental effort for the surgeon whilst giving them the ability to undertake more procedures on patients.
Versius – as its name suggests – has been designed to be inherently versatile, with the capability to operate across all four surgical quadrants, allowing it to be used in gynaecology, urology, upper GI and colorectal surgery.
“We’ve designed Versius with surgeons in mind. By equipping them with a remarkable tool, fit for their demanding job, we can change the way surgery is delivered. Having operated in stealth mode for the past three years, I am delighted to be able to show what our amazing team has managed to develop in such a short period of time.” said Martin Frost, CEO of CMR.
Notes to Editors:
A full range of available images can be found in the ‘Press kit‘
About CMR Surgical
CMR Surgical is a private company developing the next-generation universal robotic system for minimal access (or “keyhole”) surgery.
The vision behind CMR is to make minimal access surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically. This will transform the existing market for surgical robotics.
Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.
CMR Surgical was formed in 2014 and has its headquarters in Cambridge, United Kingdom. The company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.
Investors in CMR Surgical include ABB Technology Ventures, LGT Global, Cambridge Innovation Capital and Escala Capital.
For further information, please visit: www.cmrsurgical.com
 Industry Forecast, Accuray Research